Evidence map›Paper›PMID 36292566›Full record

ArticleGenes2022

CRISPR/Cas9-Mediated Gene Editing of

Jianghua Shi, Xiyuan Ni, Jixiang Huang, Ying Fu, Tanliu Wang, Huasheng Yu, Yaofeng Zhang

Open access · goldAbstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Improving the Traits ofPlants (Basel, Switzerland) · 2024
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jianghua ShiKey Laboratory of Digital Upland Crops of Zhejiang Province, Institute of Crop and Nuclear Technology Utilization, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China.
Xiyuan NiKey Laboratory of Digital Upland Crops of Zhejiang Province, Institute of Crop and Nuclear Technology Utilization, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China.
Jixiang HuangKey Laboratory of Digital Upland Crops of Zhejiang Province, Institute of Crop and Nuclear Technology Utilization, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China.
Ying FuKey Laboratory of Digital Upland Crops of Zhejiang Province, Institute of Crop and Nuclear Technology Utilization, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China.
Tanliu WangKey Laboratory of Digital Upland Crops of Zhejiang Province, Institute of Crop and Nuclear Technology Utilization, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China.
Huasheng YuKey Laboratory of Digital Upland Crops of Zhejiang Province, Institute of Crop and Nuclear Technology Utilization, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China.
Yaofeng ZhangKey Laboratory of Digital Upland Crops of Zhejiang Province, Institute of Crop and Nuclear Technology Utilization, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China.
ZheJiang Academy of Agricultural Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fatty acid (FA) composition determines the quality of oil from oilseed crops, and thus is a major target for genetic improvement.

Indexed as

Brassica napusCRISPR-Cas SystemsErucic AcidsFatty Acid ElongasesFatty AcidsFatty Acids, UnsaturatedGene EditingOleic AcidOxidoreductasesPlants, Genetically ModifiedErucic AcidsFatty Acid ElongasesFatty AcidsFatty Acids, UnsaturatedOleic AcidOxidoreductasesBnFAD2BnFAE1CRISPR/Cas9oleic acid

Identifiers

PMID36292566
PMCPMC9602045
OpenAlexW4296744483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.